Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Annals of the Rheumatic Diseases | journal | 6.489 Q1 | 288 | 475 | 1428 | 11149 | 12879 | 598 | 9.24 | 23.47 | 44.93 | |
2 | Lancet Rheumatology, The | journal | 4.586 Q1 | 54 | 188 | 457 | 2916 | 3154 | 165 | 7.19 | 15.51 | 51.74 | |
3 | Journal for ImmunoTherapy of Cancer | journal | 3.403 Q1 | 117 | 531 | 1395 | 22237 | 14506 | 1384 | 9.00 | 41.88 | 42.18 | |
4 | npj Vaccines | journal | 3.197 Q1 | 47 | 166 | 304 | 8553 | 2772 | 293 | 9.34 | 51.52 | 45.16 | |
5 | Emerging Microbes and Infections | journal | 2.815 Q1 | 94 | 280 | 697 | 10982 | 7654 | 580 | 12.49 | 39.22 | 46.61 | |
6 | PLoS Pathogens | journal | 2.490 Q1 | 246 | 640 | 2060 | 41900 | 13759 | 2038 | 6.69 | 65.47 | 44.17 | |
7 | Journal of Neuroinflammation | journal | 2.439 Q1 | 154 | 313 | 948 | 23356 | 9427 | 948 | 8.97 | 74.62 | 45.16 | |
8 | Immunity and Ageing | journal | 2.387 Q1 | 61 | 64 | 111 | 3937 | 860 | 105 | 7.80 | 61.52 | 47.97 | |
9 | Cell Death and Disease | journal | 2.188 Q1 | 164 | 1028 | 3018 | 54585 | 27098 | 2982 | 8.33 | 53.10 | 43.98 | |
10 | Open Biology | journal | 2.143 Q1 | 80 | 145 | 371 | 13314 | 2294 | 363 | 5.54 | 91.82 | 43.11 | |
11 | Virology: Research and Treatment | journal | 2.130 Q1 | 13 | 0 | 4 | 0 | 23 | 4 | 4.00 | 0.00 | 0.00 | |
12 | RMD Open | journal | 2.024 Q1 | 61 | 233 | 396 | 7580 | 2328 | 388 | 5.54 | 32.53 | 49.83 | |
13 | Frontiers in Immunology | journal | 2.022 Q1 | 225 | 8105 | 12532 | 580880 | 97059 | 12144 | 7.04 | 71.67 | 45.77 | |
14 | OncoImmunology | journal | 2.003 Q1 | 114 | 187 | 772 | 9874 | 5232 | 745 | 6.59 | 52.80 | 43.92 | |
15 | Inflammation and Regeneration | journal | 1.938 Q1 | 37 | 62 | 94 | 4312 | 806 | 88 | 7.92 | 69.55 | 33.77 | |
16 | Clinical and Translational Immunology | journal | 1.908 Q1 | 54 | 74 | 296 | 4412 | 1754 | 286 | 5.82 | 59.62 | 56.80 | |
17 | mAbs | journal | 1.748 Q1 | 104 | 87 | 331 | 5547 | 1941 | 330 | 5.49 | 63.76 | 35.15 | |
18 | Antibodies | journal | 1.697 Q1 | 42 | 77 | 175 | 4873 | 1108 | 172 | 4.98 | 63.29 | 41.94 | |
19 | ImmunoTargets and Therapy | journal | 1.681 Q1 | 25 | 6 | 60 | 555 | 457 | 59 | 7.28 | 92.50 | 44.44 | |
20 | Vaccines | journal | 1.655 Q1 | 85 | 2178 | 2497 | 113547 | 18817 | 2435 | 7.81 | 52.13 | 47.41 | |
21 | Antibody Therapeutics | journal | 1.648 Q1 | 21 | 30 | 64 | 1566 | 257 | 63 | 4.59 | 52.20 | 40.70 | |
22 | Arthritis Research and Therapy | journal | 1.592 Q1 | 177 | 275 | 872 | 10873 | 4638 | 851 | 4.56 | 39.54 | 40.89 | |
23 | Cell Death Discovery | journal | 1.545 Q2 | 58 | 484 | 594 | 23950 | 3845 | 576 | 6.53 | 49.48 | 43.01 | |
24 | Pathogens and Immunity | journal | 1.489 Q2 | 21 | 19 | 57 | 755 | 313 | 49 | 6.95 | 39.74 | 41.84 | |
25 | Immune Network | journal | 1.369 Q2 | 41 | 51 | 139 | 3717 | 762 | 138 | 5.99 | 72.88 | 41.63 | |
26 | Expert Review of Vaccines | journal | 1.346 Q2 | 105 | 178 | 333 | 13191 | 1886 | 316 | 6.10 | 74.11 | 44.05 | |
27 | Frontiers in Cellular and Infection Microbiology | journal | 1.308 Q2 | 120 | 2058 | 2689 | 130671 | 15818 | 2608 | 5.67 | 63.49 | 46.77 | |
28 | Biology Direct | journal | 1.117 Q2 | 81 | 41 | 78 | 2512 | 359 | 76 | 5.51 | 61.27 | 43.29 | |
29 | Virulence | journal | 1.104 Q2 | 94 | 135 | 413 | 10145 | 2126 | 400 | 4.94 | 75.15 | 44.77 | |
30 | World Allergy Organization Journal | journal | 1.097 Q2 | 56 | 103 | 278 | 5044 | 1375 | 255 | 5.09 | 48.97 | 45.41 | |
31 | Cellular Microbiology | journal | 1.096 Q2 | 157 | 22 | 395 | 1662 | 1310 | 374 | 3.38 | 75.55 | 48.33 | |
32 | Human Vaccines and Immunotherapeutics | journal | 1.041 Q2 | 93 | 664 | 1584 | 26995 | 6768 | 1418 | 4.29 | 40.66 | 47.71 | |
33 | Lupus Science and Medicine | journal | 1.035 Q2 | 39 | 92 | 157 | 3058 | 486 | 150 | 2.82 | 33.24 | 53.82 | |
34 | Cytokine: X | journal | 1.030 Q2 | 10 | 4 | 32 | 171 | 157 | 32 | 5.50 | 42.75 | 38.46 | |
35 | Clinical and Translational Allergy | journal | 1.018 Q2 | 52 | 98 | 197 | 3525 | 787 | 179 | 3.71 | 35.97 | 49.07 | |
36 | Journal of Virus Eradication | journal | 1.017 Q2 | 17 | 34 | 108 | 1137 | 323 | 91 | 3.77 | 33.44 | 44.85 | |
37 | Journal of Translational Autoimmunity | journal | 0.970 Q2 | 19 | 39 | 127 | 2457 | 535 | 126 | 4.26 | 63.00 | 46.36 | |
38 | ImmunoHorizons | journal | 0.963 Q2 | 21 | 76 | 210 | 3741 | 508 | 206 | 2.27 | 49.22 | 46.41 | |
39 | Mediators of Inflammation | journal | 0.962 Q2 | 134 | 204 | 891 | 10746 | 4224 | 878 | 4.59 | 52.68 | 43.73 | |
40 | Journal of Immunology Research | journal | 0.899 Q2 | 113 | 438 | 881 | 20887 | 3932 | 868 | 3.96 | 47.69 | 43.59 | |
41 | Journal of Inflammation Research | journal | 0.889 Q2 | 51 | 477 | 673 | 27409 | 2995 | 666 | 4.47 | 57.46 | 44.43 | |
42 | Journal of Global Antimicrobial Resistance | journal | 0.879 Q2 | 50 | 284 | 927 | 7806 | 3388 | 686 | 3.87 | 27.49 | 45.83 | |
43 | Immunological Medicine | journal | 0.855 Q2 | 22 | 25 | 82 | 1817 | 318 | 82 | 4.13 | 72.68 | 21.82 | |
44 | Allergy, Asthma and Immunology Research | journal | 0.850 Q3 | 62 | 59 | 316 | 2446 | 1015 | 272 | 2.56 | 41.46 | 45.20 | |
45 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 0.800 Q3 | 13 | 17 | 41 | 972 | 137 | 37 | 2.87 | 57.18 | 45.24 | |
46 | BMC Immunology | journal | 0.783 Q3 | 73 | 63 | 188 | 2686 | 622 | 188 | 3.00 | 42.63 | 46.36 | |
47 | JAC-Antimicrobial Resistance | journal | 0.734 Q3 | 22 | 123 | 233 | 4885 | 750 | 213 | 3.24 | 39.72 | 41.03 | |
48 | Journal of Immunotoxicology | journal | 0.679 Q3 | 48 | 15 | 59 | 584 | 199 | 59 | 3.51 | 38.93 | 39.29 | |
49 | Immunity, inflammation and disease | journal | 0.659 Q3 | 32 | 178 | 278 | 6909 | 847 | 268 | 3.08 | 38.81 | 43.99 | |
50 | Innate Immunity | journal | 0.657 Q3 | 78 | 20 | 172 | 905 | 512 | 166 | 3.03 | 45.25 | 37.23 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®